Paige
Paige raises $45M Series C at $120M valuation
Quick Facts
Paige: Series C Funding Round
Paige has successfully raised $45M in Series C funding, reaching a valuation of $120M.
Company Overview
AI cancer diagnosis platform
Funding Details
The Series C round was led by Northpond Ventures, with participation from Goldman Sachs.
Company Information
- Headquarters: New York, NY
- Founded: 2017
- Employees: 100+
- Category: HealthTech
Investment
Paige plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Northpond Ventures: Verified investor in Series C
- Goldman Sachs: Verified investor in Series C
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
